Persistent	persistent	O	O	O	O
nephrogenic	nephrogenic	O	O	OTHERS	I
diabetes	diabetes	O	DISEASE	OTHERS	I
insipidus	insipidus	O	DISEASE	OTHERS	I
following	following	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
the	the	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
who	who	O	O	O	O
developed	developed	O	O	O	O
severe	severe	O	O	O	O
hypernatraemic	hypernatraemic	O	O	O	O
dehydration	dehydration	O	DISEASE	OTHERS	I
following	following	O	O	O	O
a	a	O	O	O	O
head	head	O	O	OTHERS	I
injury	injury	O	O	OTHERS	I
.	.	O	O	O	O

Ten	ten	O	O	O	O
years	years	O	O	O	O
previously	previously	O	O	O	O
he	he	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
diagnosed	diagnosed	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
lithium-induced	lithium-induced	O	O	O	O
nephrogenic	nephrogenic	O	O	OTHERS	I
diabetes	diabetes	O	DISEASE	OTHERS	I
insipidus	insipidus	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
discontinued	discontinued	O	O	O	O
.	.	O	O	O	O

He	he	O	O	O	O
remained	remained	O	O	O	O
thirsty	thirsty	O	O	O	O
and	and	O	O	O	O
polyuric	polyuric	O	O	OTHERS	I
despite	despite	O	O	O	O
cessation	cessation	O	O	O	O
of	of	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
investigations	investigations	O	O	O	O
on	on	O	O	O	O
admission	admission	O	O	O	O
showed	showed	O	O	O	O
him	him	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
normal	normal	O	O	O	O
osmoregulated	osmoregulated	O	O	O	O
thirst	thirst	O	O	O	O
and	and	O	O	O	O
vasopressin	vasopressin	CHEMICALS	O	OTHERS	I
secretion	secretion	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
clear	clear	O	O	O	O
evidence	evidence	O	O	O	O
of	of	O	O	O	O
nephrogenic	nephrogenic	O	O	OTHERS	I
diabetes	diabetes	O	DISEASE	OTHERS	I
insipidus	insipidus	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Lithium	lithium	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
nephrogenic	nephrogenic	O	O	OTHERS	I
diabetes	diabetes	O	DISEASE	OTHERS	I
insipidus	insipidus	O	DISEASE	OTHERS	I
is	is	O	O	O	O
considered	considered	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
reversible	reversible	O	O	O	O
on	on	O	O	O	O
cessation	cessation	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
but	but	O	O	O	O
polyuria	polyuria	O	DISEASE	OTHERS	I
persisted	persisted	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
patient	patient	O	O	O	O
for	for	O	O	O	O
ten	ten	O	O	O	O
years	years	O	O	O	O
after	after	O	O	O	O
lithium	lithium	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
stopped	stopped	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
discuss	discuss	O	O	O	O
the	the	O	O	O	O
possible	possible	O	O	O	O
renal	renal	O	O	O	O
mechanisms	mechanisms	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
implications	implications	O	O	O	O
for	for	O	O	O	O
management	management	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
lithium-induced	lithium-induced	O	O	O	O
nephrogenic	nephrogenic	O	O	OTHERS	I
diabetes	diabetes	O	DISEASE	OTHERS	I
insipidus	insipidus	O	DISEASE	OTHERS	I
.	.	O	O	O	O

